Postpartum Disorders

The language clinicians use while talking to postpartum patients is critical. Learn more on best practices in treating this unique patient population.

Shulamit Bossewitch discussed nonpharmacological support for postpartum depression at the 2025 Southern Florida Psychiatry Conference.

Experts at the Southern Florida Psychiatry Conference emphasize the importance of screening for postpartum depression, highlighting effective treatments and support strategies for new mothers' mental health.

Lipocine's LPCN 1154 shows promise in treating postpartum depression, with a favorable safety profile and potential for rapid relief.

Lipocine Inc. advances LPCN 1154, an oral treatment for postpartum depression, aiming for rapid relief and improved patient access by 2026.

Untreated maternal mental health issues during pregnancy pose significant risks. Informed discussions on medication are crucial for mother and baby's well-being.

Dysphoric milk ejection reflex (D-MER) causes brief emotional distress during breastfeeding, often misdiagnosed as postpartum depression, requiring better awareness and support.

Biogen's zuranolone gains positive opinion for treating postpartum depression, promising rapid symptom relief and potential EU approval by 2025.

Deb York, PMHNP-BC, sheds light on postpartum psychiatry at the conference.

About 40% of women who have postpartum depression go unrecognized and untreated, and they are still symptomatic 3 years later.

Dr Wilsa Charles Malveaux highlights the urgent need to address mental health in Black Maternal Health Week, especially for Black mothers and athletes.

On April 7, 2025, the World Health Organization launched a yearlong initiative focused on improving maternal and newborn health.

Motherhood: what is truth vs idealized narrative?

A one-size-fits-all approach does not work—each mother’s experience with postpartum depression is unique.

Learn more about the impact birth complications and life factors may have on postpartum depression.

Here are 10 things to consider when treating a patient with mood disorders.

Melanie Barrett, MD; Anita Clayton, MD, and Carmen Kosicek, MSN, PMHNP-BC, discuss how optimizing SSRI dosage, potentially augmenting with another medication class, and intensifying psychosocial support helps address breakthrough PPD symptoms in mothers with partial response to current SSRI treatment.

Melanie Barrett, MD; Anita Clayton, MD, and Carmen Kosicek, MSN, PMHNP-BC, discuss how a mother's persistent PPD symptoms despite SSRI treatment necessitated a comprehensive reevaluation of medication dosage, additional therapeutic interventions, and closer monitoring of treatment response to achieve better symptom control.

Melanie Barrett, MD; Anita Clayton, MD, and Carmen Kosicek, MSN, PMHNP-BC, discuss how prompt intervention combining psychotherapy, social support mobilization, and potential medication options provides comprehensive care for the mother experiencing PPD symptoms at 12 weeks, with emphasis on both immediate symptom relief and long-term recovery strategies.

Melanie Barrett, MD; Anita Clayton, MD, and Carmen Kosicek, MSN, PMHNP-BC, discuss how a mother's PPD symptoms emerged gradually through increasing anxiety, intrusive thoughts, and emotional detachment, ultimately leading her to seek professional help after her partner noticed concerning behavioral changes at 12 weeks postpartum.

Melanie Barrett, MD; Anita Clayton, MD, and Carmen Kosicek, MSN, PMHNP-BC, discuss how postpartum depression treatments are evolving beyond traditional antidepressants to include rapid-acting options like brexanolone and zuranolone, along with enhanced screening and support programs for new mothers.

Check out these top tips for treating postpartum depression from the Real Psychiatry conference!

Melanie Barrett, MD; Anita Clayton, MD, and Carmen Kosicek, MSN, PMHNP-BC, discuss how effective screening tools like the Edinburgh Postnatal Depression Scale (EPDS) and PHQ-9, combined with comprehensive clinical assessments, are crucial for accurately identifying postpartum depression during routine prenatal and postnatal visits.

Melanie Barrett, MD; Anita Clayton, MD, and Carmen Kosicek, MSN, PMHNP-BC, discuss how breaking the stigma around postpartum depression requires both healthcare providers and society to normalize open conversations about maternal mental health, while encouraging mothers to seek support without shame or judgment.